Effect of gliclazide on monocyte-endothelium interactions in diabetes

Journal of Diabetes and its Complications

Volumn 14, Issue 4, 2000, Pages 215-223

  Renier, Geneviève ^a   Desfaits, Anne Cécile ^a   Serri, Omar ^a  

^a NOTRE DAME HOSPITAL   (Canada)

Author keywords

Adhesion molecules; Gliclazide; Monocyte adhesion; Oxidative stress

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLICLAZIDE; GLYCOSYLATED ALBUMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ATHEROSCLEROSIS; CELL ADHESION; CELL VIABILITY; CONFERENCE PAPER; CONTROLLED STUDY; DNA BINDING; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; MALE; MONOCYTE; OXIDATIVE STRESS; PRIORITY JOURNAL;

AGED; CELL ADHESION; DIABETES MELLITUS, TYPE 2; DNA; E-SELECTIN; ENDOTHELIUM, VASCULAR; FEMALE; GENE EXPRESSION; GLICLAZIDE; HUMANS; HYPOGLYCEMIC AGENTS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; MONOCYTES; NF-KAPPA B; RNA, MESSENGER; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0033821448     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(00)00082-9     Document Type: Conference Paper

References (37)

1. Bath P.M.W., Booth R.F.G., Hassall D.G. Monocyte-lymphocyte discrimination in a new microtitre-based adhesion assay. J Immunol Methods. 118:1989;59-65.
2. Baynes J.W. Role of oxidative stress in the development of complications in diabetes. Diabetes. 40:1991;405-412.
3. Berliner J.A., Territo M.C., Sevanian A., Ramin S., Ai Kim J., Bamshad B., Esterson M., Fogelman A.M. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest. 85:1990;1260-1266.
4. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest. 97:1968;77-89.
5. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:1976;248-254.
6. Brownlee M., Cerami A., Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med. 318:1988;1315-1321.
7. Carantoni M., Abbasi F., Chu L., Chen Y.D.I., Reaven G.M., Tsao P.S., Varasteh B., Cooke J.P. Adherence of mononuclear cells to endothelium in vitro is increased in patients with NIDDM. Diabetes Care. 20:1997;1462-1465.
8. Caruso C., Candore G., Cigna D., DiLorenzo G., Sireci G., Dieli F., Salerno A. Cytokine production in the ederly. Immunol Res. 15:1996;84-90.
9. Csallany A.S., Der Guan M., Manwaring J.D., Addis P.B. Free malonaldehyde determination in tissues by high-performance liquid chromatography. Anal Biochem. 142:1984;277-283.
10. Cushing S., Berliner J.A., Valente A.J., Territo M.C., Navad M., Parhami F., Gerrity R., Schwartz C.J., Fogelman A.M. Minimally modified low density lipoprotein induces monocyte chemotactic protein-1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA. 87:1990;5134-5138.
11. Desfaits A.C., Serri O., Renier G. Gliclazide decreases cell-mediated low density lipoprotein (LDL) oxidation and reduces monocyte adhesion to endothelial cells induced by oxidatively modified LDL. Metabolism. 46:1997;1150-1156.
12. Desfaits A.C., Serri O., Renier G. Normalization of plasma lipid peroxides, monocyte adhesion, and tumor necrosis factor-α production in NIDDM patients after gliclazide treatment. Diabetes Care. 21:1998;487-493.
13. Dosquet C., Weill D., Wautier J.L. Molecular mechanism of blood monocyte adhesion to vascular endothelial cells. Nouv Rev Hematol. 34:1992;S55-S59.
14. Endemann G., Pronzcuk A., Friedman G., Lindsey S., Alderson L., Hayes K.C. Monocyte adherence to endothelial cells in vitro is increased by beta-VLDL. Am J Pathol. 126:1987;1-6.
15. Fasching P., Veitl M., Rohac M., Streli C., Schneider B., Waldhausl W., Wagner O.F. Elevated concentrations of circulating adhesion molecules and their association with microvascular complications in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 81:1996;4313-4317.
16. Haller H., Schaper D., Ziegler W., Philipp S., Kuhlmann M., Distler A., Luft F.C. Low-density lipoprotein induces vascular adhesion molecule expression on human endothelial cells. Hypertension. 25:1995;511-516.
17. Hatch F.T. Practical methods for plasma lipoprotein analysis. Adv Lipid Res. 6:1968;1-68.
18. Jeng J.R., Chang C.H., Shieh S.M., Chiu H.C. Oxidized low-density lipoprotein enhances monocyte-endothelial cell binding against shear-stress-induced detachment. Biochim Biophys Acta. 1178:1993;221-227.
19. Jennings P.E., Scott N.A., Saniabadi A.R., Belch J.J.F. Effects of gliclazide on platelet reactivity and free radicals in type II diabetic patients: clinical assessment. Metabolism. 41:1992;36-39.
20. Kim J.A., Berliner J.A., Natarajan R.D., Nadler J.L. Evidence that glucose increases monocyte binding to human aortic endothelial cells. Diabetes. 43:1994;1103-1107.
21. Mehta A., Yang B., Khan S., Hendricks J.B., Stephen C., Mehta J.L. Oxidized low-density lipoproteins facilitate leukocyte adhesion to aortic intima without affecting endothelium-dependent relaxation: role of P-selectin. Arterioscler, Thromb, Vasc Biol. 15:1995;2076-2083.
22. Mihara M., Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem. 86:1978;271-278.
23. Mullarkey C.J., Edelstein D., Brownlee M. Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Commun. 173:1990;92-99.
24. Nagasaka Y., Fuji S., Kanako T. Effects of high glucose and sorbitol pathway on lipid peroxidation of erythrocytes. Horm Metab Res. 19:1987;89-90.
25. Nathan D.M. Long-term complications of diabetes mellitus. N Engl J Med. 328:1993;1676-1685.
26. Nishigaki I., Hagihara M., Tsunekawa H., Maseki M., Yagi K. Lipid peroxide levels of serum lipoprotein fractions of diabetic patients. Biochem Med. 25:1991;373-378.
27. O'Brien R.C., Luo M. The effects of gliclazide and other sulfonylurea on low-density lipoprotein oxidation in vitro. Metabolism. 46:1997;1-5.
28. Pongor S., Ulrich P.C., Bencsath F.A., Cerami A. Aging of proteins: isolation and identification of a fluorescent chromophore from the reaction of polypeptides with glucose. Proc Natl Acad Sci USA. 81:1984;2684-2688.
29. Quinn M.T.S., Parthasarathy S., Fong L.G., Steinberg D. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci USA. 84:1987;2995-2998.
30. Rajavashisth T.B., Andalibi A., Territo M.C., Berliner J.A., Navad M., Fogelman A.M., Lusis A.J. Induction of endothelial cell expression of granulocyte and monocyte-macrophage chemotactic factors by modified low density lipoproteins. Nature. 344:1990;254-257.
31. Schmidt A.M., Hori O., Chen J.X., Li J.F., Crandall J., Zhang J., Cao R., Yan S.D., Brett J., Stern D. Advanced glycation end products interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest. 96:1990;1395-1403.
32. Schmidt A.M., Weidman E., Lalla E., Yan S.D., Hori O., Cao R., Brett J.G., Lamster I.B. Advanced glycation end products (AGEs) induce oxidant stress in the gingiva: a potential mechanism underlying accelerated periodontal disease associated with diabetes. J Periodontal Res. 31:1996;508-551.
33. Scott N.A., Jennings P.E., Brown J., Belch J.J.F. Gliclazide: a general free radical scavenger. Eur J Pharmacol. 208:1991;175-177.
34. Setiadi H., Wautier J.L., Courillon-Mallet A., Passa P., Caen J. Increased adhesion to fibronectin and Mo-1 expression by diabetic monocytes. J Immunol. 138:1987;3230-3234.
35. Territo M.C., Berliner J.A., Almada L., Ramirez R., Fogelman A.M. Beta-very low density lipoprotein pretreatment of endothelial monolayers increases monocyte adhesion. Arteriosclerosis. 9:1989;824-828.
36. Weber C., Erl W., Weber P.C. Enhancement of monocyte adhesion to endothelial cells by oxidatively modified low-density lipoprotein is mediated by activation of CD11b. Biochem Biophys Res Commun. 206:1995;621-628.
37. Yue T.L., Wang X., Gu J.L., Ruffolo R.R. Jr., Feuerstein G.Z. Carvedilol prevents low-density lipoprotein (LDL)-enhanced monocyte adhesion to endothelial cells by inhibition of LDL oxidation. Eur J Pharmacol. 294:1995;585-591.